Traumatic Brain Injury‐associated gene network‐based prediction and population‐based validation identifies doxycycline as a repurposable medicine for Alzheimer’s Disease

Abstract

Background: Traumatic Brain Injury (TBI) is one of the most common causes of Alzheimer’s disease (AD). However, few effective treatments exist for AD, and even fewer for TBI.